Wigginton Jon Marc
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Wigginton Jon Marc. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MGNX | Sr VP, Clinical Dev. & CMO | Tax Withholding | 11,070 | $23.46 | $259,702 | Feb 26, 2018 |
| MGNX | Sr VP, Clinical Dev. & CMO | Sale | 2,524 | $20.00 | $50,480 | Jan 16, 2018 |
| MGNX | Sr VP, Clinical Dev. & CMO | Option Exercise | 5,000 | $4.70 | $23,500 | Nov 21, 2017 |
| MGNX | Sr VP, Clinical Dev. & CMO | Option Exercise | 10,000 | $4.70 | $47,000 | Oct 25, 2017 |
| MGNX | Sr VP, Clinical Dev. & CMO | Sale | 5,000 | $20.00 | $100,000 | Jun 5, 2017 |
| MGNX | Sr VP, Clinical Dev. & CMO | Option Exercise | 15,000 | $4.70 | $70,500 | Apr 19, 2017 |
| MGNX | Sr VP, Clinical Dev. & CMO | Sale | 10,000 | $29.34 | $293,400 | Oct 3, 2016 |
| MGNX | Sr VP, Clinical Dev. & CMO | Sale | 10,000 | $29.34 | $293,400 | Oct 3, 2016 |
| MGNX | Sr VP, Clinical Dev. & CMO | Sale | 10,000 | $29.34 | $293,400 | Oct 3, 2016 |
| MGNX | Sr VP Clinical Dev & CMO | Sale | 20,000 | $30.78 | $615,600 | Aug 1, 2016 |
| MGNX | Sr VP Clinical Dev & CMO | Option Exercise | 5,000 | $4.70 | $23,500 | Jul 1, 2016 |
| MGNX | Sr VP, Clinical Dev & CMO | Award / Grant | 30,000 | — | — | Feb 25, 2016 |
| MGNX | Sr VP, Clinical | Sale | 10,000 | $29.64 | $296,400 | Jan 4, 2016 |
| MGNX | Sr VP, Clinical | Option Exercise | 5,000 | $4.70 | $23,500 | Oct 1, 2015 |
| MGNX | Sr VP, Clinical | Sale | 5,000 | $21.11 | $105,550 | Oct 1, 2015 |
| MGNX | Sr VP, Clinical | Option Exercise | 10,000 | $4.70 | $47,000 | Aug 3, 2015 |
| MGNX | Sr VP, Clinical | Sale | 10,000 | $37.15 | $371,500 | Aug 3, 2015 |
| MGNX | Sr VP, Clinical | Option Exercise | 5,000 | $4.70 | $23,500 | Jul 1, 2015 |
| MGNX | Sr VP, Clinical | Option Exercise | 5,000 | $4.70 | $23,500 | Feb 2, 2015 |
| MGNX | Sr V.P., Clinical | Sale | 5,000 | $20.48 | $102,400 | Oct 1, 2014 |
| MGNX | Senior VP, Clinical Dev. | Option Exercise | 5,000 | $4.70 | $23,500 | Aug 18, 2014 |
| MGNX | Sr VP, Clinical | Sale | 5,000 | $30.86 | $154,300 | Apr 1, 2014 |